Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1982-05-18
1985-09-24
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514926, 546 48, 546 75, A61K 31485, C07D22118, C07D49106
Patent
active
045432562
ABSTRACT:
A method for providing orally effective aporphine compounds, and new compounds which are orally effective in the prevention and treatment of duodenal ulcers and in the treatment of neurological and psychiatric disorders having the following formula ##STR1## wherein R.sub.1 is lower alkyl, substituted lower alkyl, cycloalkyl, substituted cycloalkyl, lower alkenyl, substituted lower alkenyl, lower alkynyl, substituted lower alkynyl, phenyl lower alkyl, phenyl lower alkenyl and phenyl lower alkynyl, R.sub.2 and R.sub.3 are hydrogen, methyl, lower alkyl, substituted lower alkyl, cycloalkyl, substituted cycloalkyl, lower alkenyl, substituted lower alkenyl, lower alkynyl, substituted lower alkynyl, phenyl lower
REFERENCES:
patent: 3717639 (1973-02-01), Neumeyer
patent: 3717643 (1973-02-01), Archer
patent: 3810987 (1974-05-01), Saari
patent: 4126616 (1978-11-01), Hinshaw et al.
patent: 4425350 (1984-01-01), Hartenstein et al.
Anlezark et al., Psychopharmacology, 81, 135-139 (1983).
Baldessarini et al., European J. Pharmacol. 77, pp. 87-88 (1982).
Baldessarini, "Catecholamines: Basic and Clinical Frontiers", vol. 2, Proceedings of the Fourth International Catecholamine Symposium, Pacific Grove, Ca., 09/17-22/1978, Pergamon Press, pp. 1596-1598.
Bradbury et al., J. Pharm. Pharmacol. 35, pp. 494-499 (1983).
Campbell et al., Neuropharmacology, 21, pp. 953-961 (1982).
Campbell et al. (II), European J. Pharmacol., 67, pp. 139-142 (1980).
Granchelli et al. (II), J. Org. Chem., 42 (11), pp. 2014-2016 (1977).
Sperk et al., Neuropharmacology, vol. 21, pp. 1311-1316 (1982).
Szabo, The Lancet, Oct. 27, 1979, pp. 880-882 (1979).
Greene, "Protective Groups in Organic Synthesis", John Wiley & Sons, New York, pp. 108-110.
Neumeyer et al. (II), J. Med. Chem., 23, pp. 594-595 (1980).
Neumeyer et al. (III), J. Med. Chem., 24 (7), pp. 898-899 (1981).
Neumeyer et al., (IV), "Advances in Dopamine Research", Proceedings of a Satellite Symposium to the 8th International Congress of Pharmacology, Okayama, Japan, 7-81, Pergamon Press, pp. 291-295.
Smith et al., Research Communications in Chemical Pathology and Pharmacology, vol. 24, No. 3, Jun., 1979.
McOmie, Protective Groups in Organic Chemistry, Plenum Press, London and New York, (1973), pp. 121-122, 127-128, 150-151, 157-159.
Saari et al., J. Med. Chem., vol. 17, No. 10, pp. 1086-1090 (1974).
Neumeyer et al., J. Med. Chem., vol. 17, No. 10, pp. 1090-1095 (1974).
Granchelli et al., J. Org. Chem. vol. 46, pp. 2014-2017 (1977).
Ram et al., J. Org. Chem., vol. 46, pp. 2830-2831, Jun., 1981.
Lal et al., Chemical Abstracts, vol. 78, 92509j (1973).
Miller et al., Chemical Abstracts, vol. 84, 115631h (1976).
Iversen et al., Chemical Abstracts, vol. 87, 111272f (1977).
Fjalland et al., Chemical Abstracts, vol. 82, 38,708t (1975).
Sandor et al., Chemical Abstracts, vol. 87,227a (1977).
Uvnas-Wallenstein et al., Chemical Abstracts, vol. 89, 100153h (1978).
Bentley, Chemistry of the Morphine Alkaloids, Oxford, Clarendon Press 1954, p. 302.
Daus Donald G.
Northeastern University
Rivers Diana G.
LandOfFree
(-)-10,1L Methylenedioxy-N-N-propylnoraporphine and methods empl does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with (-)-10,1L Methylenedioxy-N-N-propylnoraporphine and methods empl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (-)-10,1L Methylenedioxy-N-N-propylnoraporphine and methods empl will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1613557